ArticlebioRxiv : the preprint server for biology2026
Cross-linked volumetric DNA microscopy for dense molecular-network phenotyping in intact tissue.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Resolving cellular phenotypes in full tissue context requires methods that can retain those cells' physical neighborhoods, together with the identities of individual biomolecules, in intact three-dimensional specimens. We introduce cross-linked volumetric DNA microscopy (xVDM), in which unique molecular identifiers are seeded directly into the tissue's protein matrix and linked by uniquely labeled DNA bridges to create a dense, DNA-encoded proximity network. Cell-scale molecular communities are then reconstructed directly from this network. xVDM produces denser molecular networks and broader transcriptome recovery than when these networks are nucleated by transcripts alone. xVDM maps out genetically annotated three-dimensional networks that map onto cell states and tissue regions in intact zebrafish embryos at 12, 18, and 24 hpf. Antibody-oligonucleotide conjugates extend the same framework to protein targets in human tonsil. xVDM provides a route to three-dimensional molecular phenotyping in intact specimens using only standard bench reagents and a DNA sequencer.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.